Indication

Chronic bronchitis

In the event of chronic bronchitis (with maintenance of a minimum pulmonary function of ± 50% of the normal value), long-term treatment with acetylcysteine is indicated to reduce the risk and severity of exacerbations.

cystic fibrosis

In case of cystic fibrosis, oral treatment can complement aerosol treatment because of its greater flexibility

Acute respiratory diseases.

Proposed as a symptomatic treatment intended to thin mucous and mucopurulent secretions in upper and lower respiratory tract conditions
Use

Chronic bronchitis

Adults and children > 7 years old: 600 mg per day, in 1 to 3 doses
Children 2 to 7 years old: 400 mg (120 to 600 mg) per day in 2 or 3 doses

cystic fibrosis

Adults and children > 6 years: 600 mg per day
Children 2 to 6 years old: 120 to 600 mg per day

Acute respiratory diseases

Adults and children > 7 years old: 400 to 600 mg per day in 1 to 3 doses
Children 2 to 7 years old: 400 mg (120 to 600 mg) per day in 2 or 3 doses

Administration mode

Dissolve the required amount in half a glass of water or another non-alcoholic drink (e.g. milk, fruit juice)
The product once dissolved must be used immediately
In small children, the solution obtained can be administered by means of a spoon or mixed with a bottle
Composition

Acetylcysteine EG 600 mg, effervescent tablets

The active substance is acetylcysteine, corresponding to 600 mg per effervescent tablet.
The other ingredients are anhydrous citric acid – Sodium hydrogen carbonate – Aspartame – Lemon flavor.